Non-remissive and later stage BrCa was reported to be correlated with CCL5 expression35,36, possibly due to its ability to promote pro-invasive factor MMP9 and monocyte migration to the BrCa tumor site, in which they undergo polarization allowing them to support tumor progression through angiogenesis37. The gene discussed is CCL5; the disease is invasive breast carcinoma.